EP3344064A4 - Kits and methods of using enzymes to modify polysaccharide fillers and delivery systems - Google Patents

Kits and methods of using enzymes to modify polysaccharide fillers and delivery systems Download PDF

Info

Publication number
EP3344064A4
EP3344064A4 EP16769585.7A EP16769585A EP3344064A4 EP 3344064 A4 EP3344064 A4 EP 3344064A4 EP 16769585 A EP16769585 A EP 16769585A EP 3344064 A4 EP3344064 A4 EP 3344064A4
Authority
EP
European Patent Office
Prior art keywords
kits
enzymes
methods
delivery systems
modify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16769585.7A
Other languages
German (de)
French (fr)
Other versions
EP3344064A1 (en
Inventor
Leonard B. MILLER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Aesthetic Technologies Inc
Original Assignee
Advanced Aesthetic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Aesthetic Technologies Inc filed Critical Advanced Aesthetic Technologies Inc
Publication of EP3344064A1 publication Critical patent/EP3344064A1/en
Publication of EP3344064A4 publication Critical patent/EP3344064A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0039—Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP16769585.7A 2015-03-24 2016-03-23 Kits and methods of using enzymes to modify polysaccharide fillers and delivery systems Pending EP3344064A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562137558P 2015-03-24 2015-03-24
PCT/US2016/023726 WO2016154277A1 (en) 2015-03-24 2016-03-23 Kits and methods of using enzymes to modify polysaccharide fillers and delivery systems

Publications (2)

Publication Number Publication Date
EP3344064A1 EP3344064A1 (en) 2018-07-11
EP3344064A4 true EP3344064A4 (en) 2019-08-07

Family

ID=56978996

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16769585.7A Pending EP3344064A4 (en) 2015-03-24 2016-03-23 Kits and methods of using enzymes to modify polysaccharide fillers and delivery systems

Country Status (2)

Country Link
EP (1) EP3344064A4 (en)
WO (1) WO2016154277A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11230612B2 (en) 2017-02-18 2022-01-25 Advanced Aesthetic Technologies, Inc. Kits and methods of using hyaluronidase to modify polysaccharide fillers and delivery systems

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032483A2 (en) * 2003-10-01 2005-04-14 Momenta Pharmaceuticals, Inc. Polysaccharides for pulmonary delivery of active agents
US20060067927A1 (en) * 2004-06-29 2006-03-30 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
US20100136070A1 (en) * 2008-12-03 2010-06-03 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
KR20130085017A (en) * 2012-01-18 2013-07-26 고려대학교 산학협력단 Method for preparing 3,6-anhydro-l-galactose and use of the 3,6-anhydro-l-galactose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007019554A2 (en) * 2005-08-08 2007-02-15 Momenta Pharmaceuticals, Inc. Polysaccharides for delivery of active agents
US20090274736A1 (en) * 2006-01-19 2009-11-05 Solazyme Inc. Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration
ITMI20130507A1 (en) * 2013-04-04 2014-10-05 Ghimas Spa FILLING COMPOSITION (FILLER) FOR THE TREATMENT OF LIPOATROPHIES

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005032483A2 (en) * 2003-10-01 2005-04-14 Momenta Pharmaceuticals, Inc. Polysaccharides for pulmonary delivery of active agents
US20060067927A1 (en) * 2004-06-29 2006-03-30 Massachusetts Institute Of Technology Methods and compositions related to the modulation of intercellular junctions
US20100136070A1 (en) * 2008-12-03 2010-06-03 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
KR20130085017A (en) * 2012-01-18 2013-07-26 고려대학교 산학협력단 Method for preparing 3,6-anhydro-l-galactose and use of the 3,6-anhydro-l-galactose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016154277A1 *

Also Published As

Publication number Publication date
EP3344064A1 (en) 2018-07-11
WO2016154277A1 (en) 2016-09-29

Similar Documents

Publication Publication Date Title
EP3362918A4 (en) Systems and methods of distributed optimization
EP3328399A4 (en) Modified cells and methods of therapy
EP3278287A4 (en) Systems and methods of blockchain transaction recordation
EP3390652A4 (en) Fermentative production of oligosaccharides
EP3234062A4 (en) Compositions and methods of improving hydraulic fracture network
EP3102670A4 (en) Systems, methods, and compositions relating to combiomics
EP3259124A4 (en) Resilient flooring product and methods of making same
EP3244825A4 (en) Screw-retained abutment with off-axis feature and methods of making and using same
EP3186286A4 (en) Cellulose-containing compositions and methods of making same
EP3268018A4 (en) Bacterial compositions and methods of use thereof
EP3386927A4 (en) Polymer compositions and methods of use
EP3341387A4 (en) Sialyltransferase inhibitors and uses thereof
EP3225635A4 (en) Modified butadiene polymer and modifying agent useful in production of same
EP3307278A4 (en) Hydroxypropyl beta-cyclodextrin compositions and methods
EP3344806A4 (en) Glycan arrays and method of use
EP3389674A4 (en) Cellular glycosaminoglycan compositions and methods of making and using
EP3635000A4 (en) Manabodies and methods of using
EP3596103A4 (en) Compositions and methods involving probiotic molecules
EP3226783A4 (en) Systems and methods for percutaneous division of fibrous structures
EP3199005A4 (en) Oxidied and coated articles and methods of making same
EP3193798A4 (en) Adhesive compositions and patches, and associated systems, kits, and methods
EP3271909A4 (en) Systems and methods of ultrasound simulation
EP3564270A4 (en) Method of degrading polysaccharide using ozone
EP3592837A4 (en) Integrated system to produce microalgae
EP3149187A4 (en) Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180514

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

A4 Supplementary search report drawn up and despatched

Effective date: 20190705

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/73 20060101ALI20190701BHEP

Ipc: A61Q 19/08 20060101ALI20190701BHEP

Ipc: A61K 47/36 20060101ALI20190701BHEP

Ipc: C08B 37/00 20060101ALI20190701BHEP

Ipc: A61K 31/167 20060101ALI20190701BHEP

Ipc: A61K 9/00 20060101ALI20190701BHEP

Ipc: A61K 8/66 20060101ALI20190701BHEP

Ipc: A23K 20/168 20160101ALI20190701BHEP

Ipc: A23K 20/195 20160101AFI20190701BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230718